Streetbeat News

Earnings

HSTM

HealthStream (NASDAQ:HSTM) reported Q4 earnings with an EPS of $0.15, beating estimates by 50% and marking a revenue increase of $2.04 million year-over-year. This follows a pattern of exceeding EPS estimates in previous quarters, with a notable 14.86% share price increase after last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 9:40 pm

ALB

BHP

LIT

NIKL

The EV battery metal market is facing a downturn, with significant price drops in lithium and nickel leading to paused projects and mine shutdowns. Albemarle Corp. is reevaluating a major lithium processing plant project in South Carolina due to these price declines and a slowdown in EV sales. Glencore has suspended operations at a nickel mine in New Caledonia, and BHP Group may temporarily close its Australian nickel business. The downturn has also affected related ETFs, with the Global X Lithium & Battery Tech ETF and the Sprott Nickel Miners ETF experiencing significant declines. Despite current challenges, there's potential for recovery if EV demand surges again.

Portfolio Pulse from Piero Cingari

February 19, 2024 | 8:40 pm

BTCY

Biotricity (NASDAQ:BTCY) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $-0.44. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price to past earnings reports. Shares have declined 76.78% over the last 52 weeks, indicating potential concern among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm

GATO

Gatos Silver (NYSE:GATO) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $0.10. Analysts and investors are keen on whether the company will surpass this estimate and provide positive future guidance. Gatos Silver's past earnings performance shows a pattern of not meeting EPS estimates, leading to subsequent drops in share price. However, the stock has seen a 33.41% increase over the last 52 weeks, indicating a positive outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm

AIP

Arteris (NASDAQ:AIP) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $-0.20. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows Arteris's stock price reacts significantly to earnings performance and guidance, with a mixed impact on its share price in past quarters. As of February 15, Arteris shares were trading at $7.8, marking a 24.71% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm

MFIN

Medallion Financial (MFIN) is scheduled to release its quarterly earnings report on February 20, 2024, with analysts expecting an EPS of $0.63. The company's past performance shows a trend of beating EPS estimates, leading to positive stock price movements. Shares are currently trading at $9.35, reflecting a 15.3% increase over the last 52 weeks. Investors are looking forward to not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm

NEO

NeoGenomics (NASDAQ:NEO) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $-0.02. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, NeoGenomics has shown the ability to beat EPS estimates, leading to significant stock price movements. The company's shares have seen a 9.2% increase over the last 52 weeks, trading at $7.61 as of February 15.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm

TRUE

TrueCar (NASDAQ:TRUE) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $-0.03. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. TrueCar's past earnings performance shows a pattern of not meeting EPS estimates, with the share price reacting variably. As of February 15, TrueCar shares were trading at $3.93, marking a 39.55% increase over the last 52 weeks. This performance indicates a generally positive outlook from long-term shareholders ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm

WGS

GeneDx Hldgs (NASDAQ:WGS) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $-0.75. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a 30.34% drop. Shares are currently trading at $4.45, down 67.86% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm

GATO

Gatos Silver (NYSE:GATO) is scheduled to release its quarterly earnings report on February 20, 2024, with analysts estimating an EPS of $0.10. The company's past earnings performance shows a pattern of not meeting EPS estimates, leading to subsequent drops in share price. Shares of Gatos Silver have risen 33.41% over the last 52 weeks, indicating a positive long-term shareholder outlook. Investors will be keenly watching for both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 8:01 pm